Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 276Lung Neoplasms 106Adenocarcinoma of Lung 28Mesothelioma, Malignant 22Neoplasms 19Neoplasm Metastasis 18Breast Neoplasms 13Brain Neoplasms 13Mesothelioma 10Head and Neck Neoplasms 10Ovarian Neoplasms 8Colorectal Neoplasms 8Recurrence 7Adenocarcinoma, Bronchiolo-Alveolar 7Small Cell Lung Carcinoma 6NSCLC 6Adenocarcinoma 6Parkinson Disease 4, Autosomal Dominant Lewy Body 5Meningeal Carcinomatosis 5Carcinoma 5Urinary Bladder Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Solitary Fibrous Tumor, Pleural 4Sarcoma 4Pancreatic Neoplasms 4Non-small Cell Lung Cancer Metastatic 4Laryngeal Diseases 4Carcinoma, Transitional Cell 4Uterine Neoplasms 3Uterine Cervical Neoplasms 3

Interventions

pembrolizumab 4Nivolumab 4fludarabine 3aldesleukin 3Paclitaxel 3Ipilimumab 3Cyclophosphamide 3Carboplatin 3padeliporfin 2atezolizumab 2anlotinib 2Riluzole 2Gemcitabine 2vinflunine 1sipuleucel-T 1relatlimab 1palbociclib 1olaparib 1niraparib 1motexafin gadolinium 1luprolide acetate gel depot 1lenvatinib 1ixabepilone 1cabozantinib 1Therapeutics 1Suspensions 1Surveys and Questionnaires 1Sunitinib 1Specimen Handling 1Powders 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Urogenital Neoplasms × Pemetrexed × Clear all
NCT00377520 2009-11-20

A Trial for Patients With Advanced/Recurrent Endometrial Cancer

Eli Lilly and Company

Phase 2 Completed
27 enrolled 10 charts
Gynecologic

Genital Neoplasms, Female, Neoplasms, Neoplasms by Site, Urogenital Neoplasms, Uterine Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡